Hiroyuki Uetake

Tokyo, 1900014, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 160 publications

A Case of Hepatic Oligometastasis from Distal Bile Duct Cancer Treated with Laparoscopic Surgery Five Years after Pancreatoduodenectomy

A Case of Hepatic Oligometastasis from Distal Bile Duct Cancer Treated with Laparoscopic Surgery Five Years after Pancreatoduodenectomy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 17, 2026

Impact of Distributing Test Result Reports for Chronic Viral Hepatitis on Awareness of Hepatitis Testing Among Non-Specialist Physicians.

Impact of Distributing Test Result Reports for Chronic Viral Hepatitis on Awareness of Hepatitis Testing Among Non-Specialist Physicians.

Journal: Medicina (Kaunas, Lithuania)

Published: October 19, 2025

Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.

Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum.

Journal: International journal of clinical oncology

Published: June 24, 2025

Efficacy of liquid biopsy in colorectal cancer.

Efficacy of liquid biopsy in colorectal cancer.

Journal: Journal of gastrointestinal oncology

Published: April 03, 2025

Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multi-centre study.

Prediction of long-term recurrence-free and overall survival in early-onset colorectal cancer: the ENCORE multi-centre study.

Journal: NPJ precision oncology

Published: February 13, 2025

The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyridine Single Therapy to the Oxaliplatin Regimen.

The Current Status of Adjuvant Chemotherapy for Colorectal Cancer in Japan: A Paradigm Shift from Oral Fluoropyridine Single Therapy to the Oxaliplatin Regimen.

Journal: Cancers

Published: December 10, 2024

Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis

Long-Term Suppression with First-Line Chemotherapy(FOLFIRI plus BV)for Peritoneal Metastasis

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: March 07, 2024

A Case of Jejunal Ectopic Pancreas Incidentally Found in Laparoscopic Rectal Cancer Surgery

A Case of Jejunal Ectopic Pancreas Incidentally Found in Laparoscopic Rectal Cancer Surgery

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: February 02, 2024

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.

Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.

Journal: Nature medicine

Published: September 29, 2023

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer.

Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: June 07, 2023

Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer.

Clinical significance of Bacteroides fragilis as a potential prognostic factor in colorectal cancer.

Journal: Anaerobe

Published: May 22, 2023

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Journal: JAMA

Published: April 18, 2023

Showing 1-12 of 160

Last Updated: 09/26/2026